F. van Valen

1.9k total citations
47 papers, 1.5k citations indexed

About

F. van Valen is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, F. van Valen has authored 47 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 16 papers in Oncology and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in F. van Valen's work include Sarcoma Diagnosis and Treatment (14 papers), Cell death mechanisms and regulation (6 papers) and Neuroblastoma Research and Treatments (6 papers). F. van Valen is often cited by papers focused on Sarcoma Diagnosis and Treatment (14 papers), Cell death mechanisms and regulation (6 papers) and Neuroblastoma Research and Treatments (6 papers). F. van Valen collaborates with scholars based in Germany, United States and Austria. F. van Valen's co-authors include Barbara Dockhorn‐Dworniczak, Klaus‐Michael Debatin, Simone Fulda, Éric Meyer, H. Jürgens, W. Winkelmann, Winfried Winkelmann, Heribert Jürgens, Christopher Poremba and Joachim Boos and has published in prestigious journals such as Cancer Research, Oncogene and Clinical Cancer Research.

In The Last Decade

F. van Valen

47 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. van Valen Germany 22 844 491 420 272 221 47 1.5k
Lauri Miller United States 12 998 1.2× 444 0.9× 348 0.8× 273 1.0× 387 1.8× 16 2.1k
Bryan K. McCune United States 17 1.1k 1.3× 557 1.1× 303 0.7× 138 0.5× 253 1.1× 26 2.0k
Naoki Maehara Japan 23 780 0.9× 798 1.6× 174 0.4× 164 0.6× 367 1.7× 85 1.8k
Keith S. K. Fong United States 18 1.2k 1.4× 201 0.4× 205 0.5× 265 1.0× 201 0.9× 30 1.8k
Marius Maxwell United States 12 474 0.6× 201 0.4× 316 0.8× 119 0.4× 143 0.6× 19 1.2k
Kazushige Sakaguchi Japan 18 838 1.0× 578 1.2× 166 0.4× 690 2.5× 93 0.4× 75 1.9k
Suzanne Lam Netherlands 16 838 1.0× 530 1.1× 131 0.3× 138 0.5× 119 0.5× 22 1.3k
Hiroyasu Nagahama Japan 17 1.0k 1.2× 697 1.4× 127 0.3× 236 0.9× 222 1.0× 30 1.8k
Tatsuo Morimura Japan 20 611 0.7× 348 0.7× 112 0.3× 175 0.6× 138 0.6× 46 1.2k
Amaya García de Vinuesa Netherlands 20 975 1.2× 289 0.6× 188 0.4× 181 0.7× 264 1.2× 24 1.6k

Countries citing papers authored by F. van Valen

Since Specialization
Citations

This map shows the geographic impact of F. van Valen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. van Valen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. van Valen more than expected).

Fields of papers citing papers by F. van Valen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. van Valen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. van Valen. The network helps show where F. van Valen may publish in the future.

Co-authorship network of co-authors of F. van Valen

This figure shows the co-authorship network connecting the top 25 collaborators of F. van Valen. A scholar is included among the top collaborators of F. van Valen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. van Valen. F. van Valen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Evans, Christopher H., Fangjun Liu, Ryan M. Porter, et al.. (2012). EWS-FLI-1-Targeted Cytotoxic T-cell Killing of Multiple Tumor Types Belonging to the Ewing Sarcoma Family of Tumors. Clinical Cancer Research. 18(19). 5341–5351. 39 indexed citations
2.
Hotfilder, Marc, et al.. (2005). PI3K/AKT is involved in mediating survival signals that rescue Ewing tumour cells from fibroblast growth factor 2-induced cell death. British Journal of Cancer. 92(4). 705–710. 33 indexed citations
3.
Schaefer, Karl‐Ludwig, Daniel Wai, Yvonne Braun, et al.. (2004). Expression Profiling of t(12;22) Positive Clear Cell Sarcoma of Soft Tissue Cell Lines Reveals Characteristic Up-Regulation of Potential New Marker Genes Including ERBB3 . Cancer Research. 64(10). 3395–3405. 56 indexed citations
4.
Valen, F. van, Simone Fulda, Karl‐Ludwig Schäfer, et al.. (2003). Selective and nonselective toxicity of TRAIL/Apo2L combined with chemotherapy in human bone tumour cells vs. normal human cells. International Journal of Cancer. 107(6). 929–940. 39 indexed citations
5.
Franzius, Christiane, Klaus Kopka, F. van Valen, et al.. (2002). 3-[123I]Iodo-L-α-methyl tyrosine transport into human fibroblasts and comparison with Ewing’s sarcoma cells. Nuclear Medicine and Biology. 29(4). 483–490. 2 indexed citations
6.
Wai, Daniel, Christopher Poremba, Eberhard Korsching, et al.. (2002). Characterization of the malignant melanoma of soft-parts cell line GG-62 by expression analysis using DNA microarrays. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 440(5). 476–484. 21 indexed citations
7.
Vormoor, Josef, Marc Hotfilder, Karl‐Ludwig Schäfer, et al.. (2001). Establishment of an In Vivo Model for Pediatric Ewing Tumors by Transplantation into NOD/ scid Mice. Pediatric Research. 49(3). 332–341. 26 indexed citations
8.
Sonnemann, Jürgen, et al.. (2001). The bisphosphonate pamidronate is a potent inhibitor of human osteosarcoma cell growth in vitro. Anti-Cancer Drugs. 12(5). 459–465. 70 indexed citations
9.
Franzius, Christiane, et al.. (2001). Characterization of 3-[123I]iodo-L-α-methyl tyrosine ([123I]IMT) transport into human Ewing’s sarcoma cells in vitro. Nuclear Medicine and Biology. 28(2). 123–128. 12 indexed citations
10.
Fulda, Simone, et al.. (2001). Sensitization for death receptor- or drug-induced apoptosis by re-expression of caspase-8 through demethylation or gene transfer. Oncogene. 20(41). 5865–5877. 324 indexed citations
11.
Valen, F. van, Simone Fulda, Jürgen Sonnemann, et al.. (2000). Apoptotic responsiveness of the Ewing's sarcoma family of tumours to tumour necrosis factor-related apoptosis-inducing ligand (TRAIL). International Journal of Cancer. 88(2). 252–259. 49 indexed citations
12.
13.
Dockhorn‐Dworniczak, Barbara, S. Blasius, W. Böcker, et al.. (1994). Diagnostic value of the molecular genetic detection of the t(11;22) translocation in Ewing's tumours. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 425(2). 107–112. 49 indexed citations
14.
Dockhorn‐Dworniczak, Barbara, S. Blasius, F. van Valen, et al.. (1994). Molekulargenetischer Nachweis der t(11;22)(q24;q12)-Translokation in Ewing-Sarkomen und malignen peripheren neuroektodermalen Tumoren (MPNT). Der Pathologe. 15(2). 103–112. 5 indexed citations
15.
Valen, F. van, et al.. (1993). Interferonγ and tumour necrosis factorα induce a synergistic antiproliferative response in human Ewing's sarcoma cells in vitro. Journal of Cancer Research and Clinical Oncology. 119(10). 615–621. 25 indexed citations
16.
Valen, F. van, W. Winkelmann, & Heribert Jürgens. (1992). Expression of functional Y1 receptors for neuropeptide Y in human Ewing's sarcoma cell lines. Journal of Cancer Research and Clinical Oncology. 118(7). 529–536. 23 indexed citations
17.
Valen, F. van, et al.. (1991). Defective Interferon Gamma Production in Neonatal T Cells Is Independent of Interleukin-2 Receptor Binding. Pediatric Research. 30(3). 270–275. 24 indexed citations
18.
Valen, F. van, H. Jürgens, W. Winkelmann, & E. Keck. (1989). Vasoactive intestinal peptide receptor regulation of cAMP accumulation and glycogen hydrolysis in the human Ewing's sarcoma cell line WE-68. Cellular Signalling. 1(5). 435–446. 6 indexed citations
19.
Valen, F. van & E. Keck. (1988). Induction of glycogenolysis in cultured Ewing's sarcoma cells by dopamine and β-adrenergic agonists. Journal of Cancer Research and Clinical Oncology. 114(3). 266–272. 10 indexed citations
20.
Valen, F. van, Reinhard Prior, W. Wechsler, et al.. (1988). Immunzytochemische und biochemische Untersuchungen an einer Ewing-Sarkom-Zellinie: Hinweise für eine neurale in-vitro Differenzierung*. Klinische Pädiatrie. 200(3). 267–270. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lauri Miller Breakdown of academic impact, for papers by Bryan K. McCune Breakdown of academic impact, for papers by Naoki Maehara Breakdown of academic impact, for papers by Keith S. K. Fong Breakdown of academic impact, for papers by Marius Maxwell Breakdown of academic impact, for papers by Kazushige Sakaguchi Breakdown of academic impact, for papers by Suzanne Lam Breakdown of academic impact, for papers by Hiroyasu Nagahama Breakdown of academic impact, for papers by Tatsuo Morimura Breakdown of academic impact, for papers by Amaya García de Vinuesa
Rankless by CCL
2026